Top compounds associated with response to MAMDC4


Feature Type Standardized
Nominal ANOVA
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.23 2e-11
mRNA linifanib CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA RITA CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.14 3e-06
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.13 8e-05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.13 0.0001
Download CSV